You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 5,583,141


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,583,141
Title: Heterocyclic compounds and their use as angiotensin antagonists
Abstract:
Inventor(s): Naka; Takehiko (Hyogo, JP), Inada; Yoshiyuki (Hyogo, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:08/291,435
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,583,141

To conduct a detailed analysis of the scope and claims of United States Patent 5,583,141, it is essential to follow a structured approach that includes understanding the patent's context, analyzing its claims, and evaluating its position within the broader patent landscape.

Patent Overview

United States Patent 5,583,141, though not specified in the provided sources, typically involves a detailed description of the invention, including its background, summary, and detailed description of the preferred embodiments. Here, we will outline a general approach to analyzing such a patent.

Claim Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of protection granted by the patent. Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Claim Interpretation

To understand the scope of the patent, it is crucial to interpret the claims carefully. This involves identifying the key elements of each claim and determining how they interact to define the invention. The USPTO guidance, such as the 2024 update on AI patents, emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

Scope of Protection

Literal Infringement

The scope of protection is determined by the literal meaning of the claims. Any product or process that meets all the elements of a claim, either literally or through the doctrine of equivalents, could be considered an infringement.

Doctrine of Equivalents

This doctrine allows for the protection of equivalents that are not literally described in the claims but perform substantially the same function in substantially the same way to achieve substantially the same result.

Patent Landscape Analysis

Define Scope and Keywords

To analyze the patent landscape around US Patent 5,583,141, start by defining the technology field and identifying relevant keywords. This helps in searching and organizing patents related to the invention[3].

Search and Organize Patents

Use patent databases such as the USPTO's Patent Public Search tool, Global Dossier, or international databases like the European Patent Office's esp@cenet to find relevant patents. Organize these patents by factors such as filing date, assignee, and technology subcategories[4].

Identify Trends and Key Players

Recognize patterns in patent filings to identify significant contributors and trends in the technology field. This step helps in understanding the competitive landscape and potential legal vulnerabilities[3].

Analyze Citations and Evolution

Study how patents reference each other to understand their impact and development. Tools like the Common Citation Document (CCD) can consolidate prior art cited by multiple offices, providing a comprehensive view of the patent's evolution[4].

Real-World Applications and Practical Utility

Practical Applications

Highlighting the real-world applications of the claimed method or system is crucial for demonstrating patent eligibility. For example, in the 2024 USPTO guidance update, claims that specify the use of AI in a practical application, such as improving speech recognition systems, are more likely to be considered patent-eligible[1].

Comparative Analysis with Recent Guidance

Integration of Judicial Exceptions

The 2024 USPTO guidance update emphasizes the integration of judicial exceptions into practical applications. Compare the claims of US Patent 5,583,141 to the examples provided in the update to determine if they meet the criteria for patent eligibility. For instance, if the claims involve abstract ideas, assess whether they are transformed into patent-eligible subject matter by additional elements that impose meaningful limits[1].

Industry Expert Insights

Industry experts often provide valuable insights into the patent landscape. For AI-related patents, experts might highlight the importance of demonstrating concrete technological improvements and the role of human contribution in AI-assisted inventions[1].

Statistical Analysis

Patent Filings and Trends

Analyze statistical data on patent filings in the relevant technology field to identify trends and key players. This can include the number of patents filed over time, the geographic distribution of filings, and the types of inventions being patented.

Case Law and Legal Precedents

Recent Federal Circuit Decisions

The 2024 USPTO guidance update incorporates recent Federal Circuit decisions, which are crucial for understanding the latest legal standards and interpretations. Ensure that the analysis of US Patent 5,583,141 aligns with these legal precedents to maintain consistency and clarity in the application of patent eligibility criteria[1].

Competitive Landscape

Identifying Key Players

Identify the key players in the technology field by analyzing patent filings and citations. This helps in understanding the competitive landscape and potential legal vulnerabilities.

Legal Vulnerabilities

Office Actions and Citations

Use tools like the Global Dossier and the Common Citation Document to identify office actions and citations related to the patent. This can reveal potential legal vulnerabilities and areas where the patent might be challenged[4].

Strategic Decisions

Generating Insights

Translate the analysis outcomes into practical guidance for strategic decisions. Evaluate the competitive landscape, potential legal vulnerabilities, and the overall position of US Patent 5,583,141 within the patent landscape to inform business and legal strategies[3].

Key Takeaways

  • Claim Interpretation: Carefully interpret the claims to understand the scope of protection.
  • Practical Applications: Highlight real-world applications to demonstrate patent eligibility.
  • Patent Landscape Analysis: Define scope, search and organize patents, identify trends, and analyze citations.
  • Legal Precedents: Align analysis with recent Federal Circuit decisions and USPTO guidance.
  • Competitive Landscape: Identify key players and potential legal vulnerabilities.

FAQs

1. What is the importance of claim interpretation in patent analysis?

Claim interpretation is crucial as it defines the scope of protection granted by the patent. It helps in determining whether a product or process infringes on the patent.

2. How does the doctrine of equivalents impact patent scope?

The doctrine of equivalents allows for the protection of equivalents that are not literally described in the claims but perform substantially the same function in substantially the same way to achieve substantially the same result.

3. What role does the 2024 USPTO guidance update play in AI patent eligibility?

The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and the significance of human contribution in AI-assisted inventions.

4. How can patent landscape analysis inform strategic decisions?

Patent landscape analysis provides insights into the competitive landscape, identifies key players, and reveals potential legal vulnerabilities, all of which are crucial for informing business and legal strategies.

5. What tools are available for searching and analyzing patents?

Tools include the USPTO's Patent Public Search, Global Dossier, Common Citation Document (CCD), and international databases like the European Patent Office's esp@cenet.

Cited Sources:

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. US-20100105709-A1 - Unified Patents Portal.
  3. How to Do Patent Landscape Analysis - Goldstein Patent Law.
  4. Search for patents - USPTO.
  5. Solid pharmaceutical composition - Patent US-9173849-B2 - PubChem.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,583,141

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,583,141

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-157194Jun 27, 1991
Japan3-188882Jul 29, 1991
Japan3-192054Jul 31, 1991
Japan3-288217Aug 12, 1991
Japan3-239766Sep 19, 1991
Japan3-341107Dec 24, 1991

International Family Members for US Patent 5,583,141

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 240323 ⤷  Subscribe
Australia 1859892 ⤷  Subscribe
Australia 646343 ⤷  Subscribe
Canada 2072541 ⤷  Subscribe
China 1040755 ⤷  Subscribe
China 1064044 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.